Polymyxin resistance in Enterobacterales: overview and epidemiology in the Americas

J Rodríguez-Santiago1, P Cornejo-Juárez2, J Silva-Sánchez3

  • 1Instituto Nacional de Salud Pública (INSP), Centro de Investigación sobre Enfermedades Infecciosas (CISEI), Laboratorio de Resistencia Bacteriana, Cuernavaca, Morelos, México; Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, México.

Insights

Carbapenem- and polymyxin-resistant Enterobacterales are a global threat. This study highlights limited data in the Americas, suggesting urgent surveillance and regulatory measures for antimicrobial use in veterinary medicine.

Area of Science:

  • Microbiology
  • Public Health
  • Infectious Diseases

Background:

  • The global rise of carbapenem- and polymyxin-resistant Enterobacterales (CPRE) poses a significant public health challenge.
  • Limited data exists on CPRE epidemiology in the Americas, with Latin America suspected as a reservoir for plasmid-mediated polymyxin resistance.
  • Polymyxins are critical last-resort antibiotics, making resistance a growing concern.

Purpose of the Study:

  • To provide an updated overview of polymyxin use, availability, and resistance.
  • To review the current epidemiology of polymyxin resistance in Enterobacterales across the Americas.
  • To identify gaps in surveillance and propose regulatory measures.

Main Methods:

  • Literature review of English and Spanish publications on polymyxin resistance in Enterobacterales in the Americas.
  • Analysis of data on carbapenemase-producing and colistin-resistant Klebsiella pneumoniae and Escherichia coli.
  • Examination of plasmid-mediated resistance mechanisms, including mcr-1.

Main Results:

  • Widespread carbapenemase-producing and colistin-resistant Klebsiella pneumoniae (ST258 clone, mgrB mutations) identified in the Americas.
  • Prevalence of IncI2 and IncX4 plasmids carrying mcr-1 in Escherichia coli, primarily from human sources.
  • Underreporting of plasmid-mediated colistin resistance in the veterinary sector across the Americas.

Conclusions:

  • Urgent need for enhanced surveillance of polymyxin resistance in Enterobacterales in the Americas.
  • Implementation of regulatory measures for antimicrobial use in veterinary medicine is crucial.
  • Addressing resistance requires a One Health approach, considering human, animal, and environmental sectors.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
592
Antibiotic Selection00:57

Antibiotic Selection

Overview
56.7K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
155
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
579
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.2K